APO Research
Talk to an analyst

APO RESEARCH · REPORT

Allylamines Antifungal Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Allylamines Antifungal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025192 pages

Choose your research edition.

Industry ResearchAllylamines Antifungal Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Allylamines Antifungal Drugs Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Allylamines Antifungal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Allylamines Antifungal Drugs Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Allylamines Antifungal Drugs Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Allylamines Antifungal Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Allylamines Antifungal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Allylamines Antifungal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Allylamines Antifungal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Allylamines Antifungal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Allylamines Antifungal Drugs include Chongqing Huapont Pharmaceutical, Yangtze River Pharmaceutical Group, Xiuzheng Pharmaceutical Group, Tongyao Pharmaceutical Group, Teva, Shandong Chenxin Pharmaceutical, Sandoz, Qilu Pharmaceutical and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Allylamines Antifungal Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Allylamines Antifungal Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Allylamines Antifungal Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Allylamines Antifungal Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Allylamines Antifungal Drugs Segment by Company

Chongqing Huapont Pharmaceutical

Yangtze River Pharmaceutical Group

Xiuzheng Pharmaceutical Group

Tongyao Pharmaceutical Group

Teva

Shandong Chenxin Pharmaceutical

Sandoz

Qilu Pharmaceutical

Novartis

Nanjing Chenggong Pharmaceutical

Mylan

Pfizer

Hunan Dinuo Pharmaceutical

Fuyuan Pharmaceutical

Bayer

Aobang Pharmaceutical

Gilead Sciences

Dr. Reddy's Laboratories

Cipla

Abbott Laboratories

Allylamines Antifungal Drugs Segment by Type

Terbinafine

Naftifine

Butenafine

Others

Allylamines Antifungal Drugs Segment by Application

Tinea Capitis

Dermatophytosis

Candidiasis

Tinea Versicolor

Others

Allylamines Antifungal Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allylamines Antifungal Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allylamines Antifungal Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allylamines Antifungal Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Allylamines Antifungal Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Allylamines Antifungal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Allylamines Antifungal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Allylamines Antifungal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Allylamines Antifungal Drugs Industry Trends Table 2. Allylamines Antifungal Drugs Industry Drivers Table 3. Allylamines Antifungal Drugs Industry Opportunities and Challenges Table 4. Allylamines Antifungal Drugs Industry Restraints Table 5. Global Allylamines Antifungal Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Allylamines Antifungal Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Allylamines Antifungal Drugs Sales by Manufacturers (units) & (2021-2026) Table 8. Global Allylamines Antifungal Drugs Sales Market Share by Manufacturers Table 9. Global Allylamines Antifungal Drugs Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Allylamines Antifungal Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Allylamines Antifungal Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Allylamines Antifungal Drugs Manufacturers, Product Type & Application Table 13. Global Allylamines Antifungal Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Allylamines Antifungal Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Terbinafine Table 17. Major Manufacturers of Naftifine Table 18. Major Manufacturers of Butenafine Table 19. Major Manufacturers of Others Table 20. Global Allylamines Antifungal Drugs Sales by Type 2021 VS 2025 VS 2032 (units) Table 21. Global Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 22. Global Allylamines Antifungal Drugs Sales by Type (2027-2032) & (units) Table 23. Global Allylamines Antifungal Drugs Sales Market Share by Type (2021-2026) Table 24. Global Allylamines Antifungal Drugs Sales Market Share by Type (2027-2032) Table 25. Global Allylamines Antifungal Drugs Revenue by Type 2021 VS 2025 VS 2032 (units) Table 26. Global Allylamines Antifungal Drugs Revenue by Type (2021-2026) & (units) Table 27. Global Allylamines Antifungal Drugs Revenue by Type (2027-2032) & (units) Table 28. Global Allylamines Antifungal Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Allylamines Antifungal Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Tinea Capitis Table 31. Major Manufacturers of Dermatophytosis Table 32. Major Manufacturers of Candidiasis Table 33. Major Manufacturers of Tinea Versicolor Table 34. Major Manufacturers of Others Table 35. Global Allylamines Antifungal Drugs Sales by Application 2021 VS 2025 VS 2032 (units) Table 36. Global Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 37. Global Allylamines Antifungal Drugs Sales by Application (2027-2032) & (units) Table 38. Global Allylamines Antifungal Drugs Sales Market Share by Application (2021-2026) Table 39. Global Allylamines Antifungal Drugs Sales Market Share by Application (2027-2032) Table 40. Global Allylamines Antifungal Drugs Revenue by Application 2021 VS 2025 VS 2032 (units) Table 41. Global Allylamines Antifungal Drugs Revenue by Application (2021-2026) & (units) Table 42. Global Allylamines Antifungal Drugs Revenue by Application (2027-2032) & (units) Table 43. Global Allylamines Antifungal Drugs Revenue Market Share by Application (2021-2026) Table 44. Global Allylamines Antifungal Drugs Revenue Market Share by Application (2027-2032) Table 45. Global Allylamines Antifungal Drugs Sales by Region: 2021 VS 2025 VS 2032 (units) Table 46. Global Allylamines Antifungal Drugs Sales by Region (2021-2026) & (units) Table 47. Global Allylamines Antifungal Drugs Sales Market Share by Region (2021-2026) Table 48. Global Allylamines Antifungal Drugs Sales Forecasted by Region (2027-2032) & (units) Table 49. Global Allylamines Antifungal Drugs Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Allylamines Antifungal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 51. North America Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 52. North America Allylamines Antifungal Drugs Sales by Country (2027-2032) & (units) Table 53. Europe Allylamines Antifungal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 54. Europe Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 55. Europe Allylamines Antifungal Drugs Sales by Country (2027-2032) & (units) Table 56. Asia Pacific Allylamines Antifungal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 57. Asia Pacific Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 58. Asia Pacific Allylamines Antifungal Drugs Sales by Country (2027-2032) & (units) Table 59. South America, Middle East and Africa Allylamines Antifungal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 60. South America, Middle East and Africa Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 61. South America, Middle East and Africa Allylamines Antifungal Drugs Sales by Country (2027-2032) & (units) Table 62. Global Allylamines Antifungal Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Allylamines Antifungal Drugs Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Allylamines Antifungal Drugs Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Allylamines Antifungal Drugs Revenue Market Share by Region (2021-2026) Table 66. Global Allylamines Antifungal Drugs Revenue Market Share by Region (2027-2032) Table 67. Chongqing Huapont Pharmaceutical Company Information Table 68. Chongqing Huapont Pharmaceutical Business Overview Table 69. Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 71. Chongqing Huapont Pharmaceutical Recent Development Table 72. Yangtze River Pharmaceutical Group Company Information Table 73. Yangtze River Pharmaceutical Group Business Overview Table 74. Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio Table 76. Yangtze River Pharmaceutical Group Recent Development Table 77. Xiuzheng Pharmaceutical Group Company Information Table 78. Xiuzheng Pharmaceutical Group Business Overview Table 79. Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio Table 81. Xiuzheng Pharmaceutical Group Recent Development Table 82. Tongyao Pharmaceutical Group Company Information Table 83. Tongyao Pharmaceutical Group Business Overview Table 84. Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio Table 86. Tongyao Pharmaceutical Group Recent Development Table 87. Teva Company Information Table 88. Teva Business Overview Table 89. Teva Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Teva Allylamines Antifungal Drugs Product Portfolio Table 91. Teva Recent Development Table 92. Shandong Chenxin Pharmaceutical Company Information Table 93. Shandong Chenxin Pharmaceutical Business Overview Table 94. Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 96. Shandong Chenxin Pharmaceutical Recent Development Table 97. Sandoz Company Information Table 98. Sandoz Business Overview Table 99. Sandoz Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Sandoz Allylamines Antifungal Drugs Product Portfolio Table 101. Sandoz Recent Development Table 102. Qilu Pharmaceutical Company Information Table 103. Qilu Pharmaceutical Business Overview Table 104. Qilu Pharmaceutical Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Qilu Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 106. Qilu Pharmaceutical Recent Development Table 107. Novartis Company Information Table 108. Novartis Business Overview Table 109. Novartis Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Novartis Allylamines Antifungal Drugs Product Portfolio Table 111. Novartis Recent Development Table 112. Nanjing Chenggong Pharmaceutical Company Information Table 113. Nanjing Chenggong Pharmaceutical Business Overview Table 114. Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 116. Nanjing Chenggong Pharmaceutical Recent Development Table 117. Mylan Company Information Table 118. Mylan Business Overview Table 119. Mylan Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Mylan Allylamines Antifungal Drugs Product Portfolio Table 121. Mylan Recent Development Table 122. Pfizer Company Information Table 123. Pfizer Business Overview Table 124. Pfizer Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Pfizer Allylamines Antifungal Drugs Product Portfolio Table 126. Pfizer Recent Development Table 127. Hunan Dinuo Pharmaceutical Company Information Table 128. Hunan Dinuo Pharmaceutical Business Overview Table 129. Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 131. Hunan Dinuo Pharmaceutical Recent Development Table 132. Fuyuan Pharmaceutical Company Information Table 133. Fuyuan Pharmaceutical Business Overview Table 134. Fuyuan Pharmaceutical Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Fuyuan Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 136. Fuyuan Pharmaceutical Recent Development Table 137. Bayer Company Information Table 138. Bayer Business Overview Table 139. Bayer Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Bayer Allylamines Antifungal Drugs Product Portfolio Table 141. Bayer Recent Development Table 142. Aobang Pharmaceutical Company Information Table 143. Aobang Pharmaceutical Business Overview Table 144. Aobang Pharmaceutical Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Aobang Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 146. Aobang Pharmaceutical Recent Development Table 147. Gilead Sciences Company Information Table 148. Gilead Sciences Business Overview Table 149. Gilead Sciences Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Gilead Sciences Allylamines Antifungal Drugs Product Portfolio Table 151. Gilead Sciences Recent Development Table 152. Dr. Reddy's Laboratories Company Information Table 153. Dr. Reddy's Laboratories Business Overview Table 154. Dr. Reddy's Laboratories Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Dr. Reddy's Laboratories Allylamines Antifungal Drugs Product Portfolio Table 156. Dr. Reddy's Laboratories Recent Development Table 157. Cipla Company Information Table 158. Cipla Business Overview Table 159. Cipla Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Cipla Allylamines Antifungal Drugs Product Portfolio Table 161. Cipla Recent Development Table 162. Abbott Laboratories Company Information Table 163. Abbott Laboratories Business Overview Table 164. Abbott Laboratories Allylamines Antifungal Drugs Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. Abbott Laboratories Allylamines Antifungal Drugs Product Portfolio Table 166. Abbott Laboratories Recent Development Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Allylamines Antifungal Drugs Distributors List Table 170. Allylamines Antifungal Drugs Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Allylamines Antifungal Drugs Product Image Figure 2. Global Allylamines Antifungal Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Allylamines Antifungal Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Allylamines Antifungal Drugs Sales (2021-2032) & (units) Figure 5. Global Allylamines Antifungal Drugs Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Allylamines Antifungal Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Terbinafine Image Figure 9. Naftifine Image Figure 10. Butenafine Image Figure 11. Others Image Figure 12. Global Allylamines Antifungal Drugs Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 13. Global Allylamines Antifungal Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Allylamines Antifungal Drugs Sales Market Share by Type (2021-2032) Figure 15. Global Allylamines Antifungal Drugs Revenue by Type (2021 VS 2025 VS 2032) & (units) Figure 16. Global Allylamines Antifungal Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Allylamines Antifungal Drugs Revenue Market Share by Type (2021-2032) Figure 18. Tinea Capitis Image Figure 19. Dermatophytosis Image Figure 20. Candidiasis Image Figure 21. Tinea Versicolor Image Figure 22. Others Image Figure 23. Global Allylamines Antifungal Drugs Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 24. Global Allylamines Antifungal Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Allylamines Antifungal Drugs Sales Market Share by Application (2021-2032) Figure 26. Global Allylamines Antifungal Drugs Revenue by Application (2021 VS 2025 VS 2032) & (units) Figure 27. Global Allylamines Antifungal Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Allylamines Antifungal Drugs Revenue Market Share by Application (2021-2032) Figure 29. North America Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 30. North America Allylamines Antifungal Drugs Sales Market Share by Country (2021-2032) Figure 31. U.S. Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 32. Canada Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 33. Mexico Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 34. Europe Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 35. Europe Allylamines Antifungal Drugs Sales Market Share by Country (2021-2032) Figure 36. Germany Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 37. France Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 38. U.K. Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 39. Italy Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 40. Netherlands Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 41. Asia Pacific Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 42. Asia Pacific Allylamines Antifungal Drugs Sales Market Share by Country (2021-2032) Figure 43. China Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 44. Japan Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 45. South Korea Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 46. Southeast Asia Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 47. India Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 48. Australia Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 49. South America, Middle East and Africa Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 50. South America, Middle East and Africa Allylamines Antifungal Drugs Sales Market Share by Country (2021-2032) Figure 51. Brazil Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 52. South Africa Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 53. Saudi Arabia Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 54. Turkey Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 55. Argentina Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 56. UAE Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 57. Egypt Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 58. Chile Allylamines Antifungal Drugs Sales and Growth Rate (2021-2032) & (units) Figure 59. Global Allylamines Antifungal Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Allylamines Antifungal Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Figure 62. North America Allylamines Antifungal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Europe Allylamines Antifungal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Allylamines Antifungal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Allylamines Antifungal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Allylamines Antifungal Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Allylamines Antifungal Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Terbinafine
  • Naftifine
  • Butenafine
  • Others
Applications
  • Tinea Capitis
  • Dermatophytosis
  • Candidiasis
  • Tinea Versicolor
  • Others
Companies covered
  • Chongqing Huapont Pharmaceutical
  • Yangtze River Pharmaceutical Group
  • Xiuzheng Pharmaceutical Group
  • Tongyao Pharmaceutical Group
  • Teva
  • Shandong Chenxin Pharmaceutical
  • Sandoz
  • Qilu Pharmaceutical
  • Novartis
  • Nanjing Chenggong Pharmaceutical
  • Mylan
  • Pfizer
  • Hunan Dinuo Pharmaceutical
  • Fuyuan Pharmaceutical
  • Bayer
  • Aobang Pharmaceutical
  • Gilead Sciences
  • Dr. Reddy's Laboratories
  • Cipla
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Allylamines Antifungal Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Allylamines Antifungal Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Allylamines Antifungal Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Allylamines Antifungal Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Allylamines Antifungal Drugs Market Dynamics
  1. 2.1 Allylamines Antifungal Drugs Industry Trends
  2. 2.2 Allylamines Antifungal Drugs Industry Drivers
  3. 2.3 Allylamines Antifungal Drugs Industry Opportunities and Challenges
  4. 2.4 Allylamines Antifungal Drugs Industry Restraints
3 Allylamines Antifungal Drugs Market by Manufacturers
  1. 3.1 Global Allylamines Antifungal Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Allylamines Antifungal Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Allylamines Antifungal Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Allylamines Antifungal Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Allylamines Antifungal Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Allylamines Antifungal Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Allylamines Antifungal Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Allylamines Antifungal Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Allylamines Antifungal Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Allylamines Antifungal Drugs Tier 1, Tier 2, and Tier 3
4 Allylamines Antifungal Drugs Market by Type
  1. 4.1 Allylamines Antifungal Drugs Type Introduction
  2. 4.1.1 Terbinafine
  3. 4.1.2 Naftifine
  4. 4.1.3 Butenafine
  5. 4.1.4 Others
  6. 4.2 Global Allylamines Antifungal Drugs Sales by Type
  7. 4.2.1 Global Allylamines Antifungal Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Allylamines Antifungal Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global Allylamines Antifungal Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Allylamines Antifungal Drugs Revenue by Type
  11. 4.3.1 Global Allylamines Antifungal Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Allylamines Antifungal Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global Allylamines Antifungal Drugs Revenue Market Share by Type (2021-2032)
5 Allylamines Antifungal Drugs Market by Application
  1. 5.1 Allylamines Antifungal Drugs Application Introduction
  2. 5.1.1 Tinea Capitis
  3. 5.1.2 Dermatophytosis
  4. 5.1.3 Candidiasis
  5. 5.1.4 Tinea Versicolor
  6. 5.1.5 Others
  7. 5.2 Global Allylamines Antifungal Drugs Sales by Application
  8. 5.2.1 Global Allylamines Antifungal Drugs Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Allylamines Antifungal Drugs Sales by Application (2021-2032)
  10. 5.2.3 Global Allylamines Antifungal Drugs Sales Market Share by Application (2021-2032)
  11. 5.3 Global Allylamines Antifungal Drugs Revenue by Application
  12. 5.3.1 Global Allylamines Antifungal Drugs Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Allylamines Antifungal Drugs Revenue by Application (2021-2032)
  14. 5.3.3 Global Allylamines Antifungal Drugs Revenue Market Share by Application (2021-2032)
6 Global Allylamines Antifungal Drugs Sales by Region
  1. 6.1 Global Allylamines Antifungal Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Allylamines Antifungal Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Allylamines Antifungal Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Allylamines Antifungal Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Allylamines Antifungal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Allylamines Antifungal Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Allylamines Antifungal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Allylamines Antifungal Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Allylamines Antifungal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Allylamines Antifungal Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Allylamines Antifungal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Allylamines Antifungal Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Allylamines Antifungal Drugs Revenue by Region
  1. 7.1 Global Allylamines Antifungal Drugs Revenue by Region
  2. 7.1.1 Global Allylamines Antifungal Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Allylamines Antifungal Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Allylamines Antifungal Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Allylamines Antifungal Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Allylamines Antifungal Drugs Revenue (2021-2032)
  8. 7.2.2 North America Allylamines Antifungal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Allylamines Antifungal Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Allylamines Antifungal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Allylamines Antifungal Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Allylamines Antifungal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Allylamines Antifungal Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Allylamines Antifungal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Huapont Pharmaceutical
  2. 8.1.1 Chongqing Huapont Pharmaceutical Company Information
  3. 8.1.2 Chongqing Huapont Pharmaceutical Business Overview
  4. 8.1.3 Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  6. 8.1.5 Chongqing Huapont Pharmaceutical Recent Developments
  7. 8.2 Yangtze River Pharmaceutical Group
  8. 8.2.1 Yangtze River Pharmaceutical Group Company Information
  9. 8.2.2 Yangtze River Pharmaceutical Group Business Overview
  10. 8.2.3 Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
  12. 8.2.5 Yangtze River Pharmaceutical Group Recent Developments
  13. 8.3 Xiuzheng Pharmaceutical Group
  14. 8.3.1 Xiuzheng Pharmaceutical Group Company Information
  15. 8.3.2 Xiuzheng Pharmaceutical Group Business Overview
  16. 8.3.3 Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
  18. 8.3.5 Xiuzheng Pharmaceutical Group Recent Developments
  19. 8.4 Tongyao Pharmaceutical Group
  20. 8.4.1 Tongyao Pharmaceutical Group Company Information
  21. 8.4.2 Tongyao Pharmaceutical Group Business Overview
  22. 8.4.3 Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
  24. 8.4.5 Tongyao Pharmaceutical Group Recent Developments
  25. 8.5 Teva
  26. 8.5.1 Teva Company Information
  27. 8.5.2 Teva Business Overview
  28. 8.5.3 Teva Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teva Allylamines Antifungal Drugs Product Portfolio
  30. 8.5.5 Teva Recent Developments
  31. 8.6 Shandong Chenxin Pharmaceutical
  32. 8.6.1 Shandong Chenxin Pharmaceutical Company Information
  33. 8.6.2 Shandong Chenxin Pharmaceutical Business Overview
  34. 8.6.3 Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  36. 8.6.5 Shandong Chenxin Pharmaceutical Recent Developments
  37. 8.7 Sandoz
  38. 8.7.1 Sandoz Company Information
  39. 8.7.2 Sandoz Business Overview
  40. 8.7.3 Sandoz Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sandoz Allylamines Antifungal Drugs Product Portfolio
  42. 8.7.5 Sandoz Recent Developments
  43. 8.8 Qilu Pharmaceutical
  44. 8.8.1 Qilu Pharmaceutical Company Information
  45. 8.8.2 Qilu Pharmaceutical Business Overview
  46. 8.8.3 Qilu Pharmaceutical Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Qilu Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  48. 8.8.5 Qilu Pharmaceutical Recent Developments
  49. 8.9 Novartis
  50. 8.9.1 Novartis Company Information
  51. 8.9.2 Novartis Business Overview
  52. 8.9.3 Novartis Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novartis Allylamines Antifungal Drugs Product Portfolio
  54. 8.9.5 Novartis Recent Developments
  55. 8.10 Nanjing Chenggong Pharmaceutical
  56. 8.10.1 Nanjing Chenggong Pharmaceutical Company Information
  57. 8.10.2 Nanjing Chenggong Pharmaceutical Business Overview
  58. 8.10.3 Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  60. 8.10.5 Nanjing Chenggong Pharmaceutical Recent Developments
  61. 8.11 Mylan
  62. 8.11.1 Mylan Company Information
  63. 8.11.2 Mylan Business Overview
  64. 8.11.3 Mylan Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Mylan Allylamines Antifungal Drugs Product Portfolio
  66. 8.11.5 Mylan Recent Developments
  67. 8.12 Pfizer
  68. 8.12.1 Pfizer Company Information
  69. 8.12.2 Pfizer Business Overview
  70. 8.12.3 Pfizer Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pfizer Allylamines Antifungal Drugs Product Portfolio
  72. 8.12.5 Pfizer Recent Developments
  73. 8.13 Hunan Dinuo Pharmaceutical
  74. 8.13.1 Hunan Dinuo Pharmaceutical Company Information
  75. 8.13.2 Hunan Dinuo Pharmaceutical Business Overview
  76. 8.13.3 Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  78. 8.13.5 Hunan Dinuo Pharmaceutical Recent Developments
  79. 8.14 Fuyuan Pharmaceutical
  80. 8.14.1 Fuyuan Pharmaceutical Company Information
  81. 8.14.2 Fuyuan Pharmaceutical Business Overview
  82. 8.14.3 Fuyuan Pharmaceutical Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Fuyuan Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  84. 8.14.5 Fuyuan Pharmaceutical Recent Developments
  85. 8.15 Bayer
  86. 8.15.1 Bayer Company Information
  87. 8.15.2 Bayer Business Overview
  88. 8.15.3 Bayer Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Allylamines Antifungal Drugs Product Portfolio
  90. 8.15.5 Bayer Recent Developments
  91. 8.16 Aobang Pharmaceutical
  92. 8.16.1 Aobang Pharmaceutical Company Information
  93. 8.16.2 Aobang Pharmaceutical Business Overview
  94. 8.16.3 Aobang Pharmaceutical Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Aobang Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  96. 8.16.5 Aobang Pharmaceutical Recent Developments
  97. 8.17 Gilead Sciences
  98. 8.17.1 Gilead Sciences Company Information
  99. 8.17.2 Gilead Sciences Business Overview
  100. 8.17.3 Gilead Sciences Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Gilead Sciences Allylamines Antifungal Drugs Product Portfolio
  102. 8.17.5 Gilead Sciences Recent Developments
  103. 8.18 Dr. Reddy's Laboratories
  104. 8.18.1 Dr. Reddy's Laboratories Company Information
  105. 8.18.2 Dr. Reddy's Laboratories Business Overview
  106. 8.18.3 Dr. Reddy's Laboratories Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Dr. Reddy's Laboratories Allylamines Antifungal Drugs Product Portfolio
  108. 8.18.5 Dr. Reddy's Laboratories Recent Developments
  109. 8.19 Cipla
  110. 8.19.1 Cipla Company Information
  111. 8.19.2 Cipla Business Overview
  112. 8.19.3 Cipla Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Cipla Allylamines Antifungal Drugs Product Portfolio
  114. 8.19.5 Cipla Recent Developments
  115. 8.20 Abbott Laboratories
  116. 8.20.1 Abbott Laboratories Company Information
  117. 8.20.2 Abbott Laboratories Business Overview
  118. 8.20.3 Abbott Laboratories Allylamines Antifungal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Abbott Laboratories Allylamines Antifungal Drugs Product Portfolio
  120. 8.20.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Allylamines Antifungal Drugs Value Chain Analysis
  2. 9.1.1 Allylamines Antifungal Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Allylamines Antifungal Drugs Production Mode & Process
  6. 9.2 Allylamines Antifungal Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Allylamines Antifungal Drugs Distributors
  9. 9.2.3 Allylamines Antifungal Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst